Literature DB >> 21517994

Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself?

Nikolaos Skartsis1, Eddie Manning, Yuntao Wei, Omaida C Velazquez, Zhao-Jun Liu, Pascal J Goldschmidt-Clermont, Loay H Salman, Arif Asif, Roberto I Vazquez-Padron.   

Abstract

To elucidate the source of neointimal cells, experimental fistulas were created in Lewis wild-type (WT) and transgenic rats that constitutively expressed the green fluorescent protein (GFP) in all tissues. Arteriovenous fistula (AVFs) were created by anastomosing the left renal vein to the abdominal aorta. The contribution of bone marrow (BM)-derived cells to the AVF neointima was examined in lethally irradiated WT rats that had been rescued with GFP BM cells. Neointimal cells in these chimeric rats were mostly GFP negative indicating the non-BM origin of those cells. Then, the contribution of arterial cells to the AVF neointima was assessed in a fistula made with a GFP aorta that had been implanted orthotopically into a WT rat. Most of the neointimal cells were also GFP negative demonstrating that AVF neointimal cells are not derived from the feeding artery. Finally to study local resident cells contribution to the formation of neointimal lesions, a composite fistula was created by interposing a GFP vein between the renal vein and the aorta in a WT recipient rat. GFP neointimal cells were only found in the transplanted vein. This study suggests that neointimal cells originate from the local resident cells in the venous limb of the fistula.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517994      PMCID: PMC4169005          DOI: 10.1111/j.1525-139X.2011.00870.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  18 in total

1.  Embracing the fistula first national vascular access improvement initiative.

Authors:  Britt H Tonnessen; Samuel R Money
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

2.  Optimizing techniques for tracking transplanted stem cells in vivo.

Authors:  Timothy R Brazelton; Helen M Blau
Journal:  Stem Cells       Date:  2005-08-18       Impact factor: 6.277

3.  Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages.

Authors:  Hiroshi Iwata; Ichiro Manabe; Katsuhito Fujiu; Tetsufumi Yamamoto; Norifumi Takeda; Kosei Eguchi; Akiko Furuya; Makoto Kuro-o; Masataka Sata; Ryozo Nagai
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

4.  Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.

Authors:  G Li; S J Chen; S Oparil; Y F Chen; J A Thompson
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 5.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

6.  Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model.

Authors:  Y Castier; S Lehoux; Y Hu; G Foteinos; G Fonteinos; A Tedgui; Q Xu
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

7.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Allometric scaling of wall shear stress from mice to humans: quantification using cine phase-contrast MRI and computational fluid dynamics.

Authors:  Joan M Greve; Andrea S Les; Beverly T Tang; Mary T Draney Blomme; Nathan M Wilson; Ronald L Dalman; Norbert J Pelc; Charles A Taylor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-19       Impact factor: 4.733

9.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.

Authors:  Yanhua Hu; Zhongyi Zhang; Evelyn Torsney; Ali R Afzal; Fergus Davison; Bernhard Metzler; Qingbo Xu
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Percutaneous management of perianastomotic stenosis in arteriovenous fistulae: results of a prospective study.

Authors:  A Asif; O Lenz; D Merrill; G Cherla; C D Cipleu; R Ellis; B Francois; D L Epstein; P Pennell
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

View more
  16 in total

1.  Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure.

Authors:  Juan C Duque; Marwan Tabbara; Laisel Martinez; Jose Cardona; Roberto I Vazquez-Padron; Loay H Salman
Journal:  Am J Kidney Dis       Date:  2016-10-27       Impact factor: 8.860

Review 2.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

Review 3.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

4.  Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes.

Authors:  Marwan Tabbara; Juan C Duque; Laisel Martinez; Luis A Escobar; Wensong Wu; Yue Pan; Natasha Fernandez; Omaida C Velazquez; Edgar A Jaimes; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Am J Kidney Dis       Date:  2016-03-22       Impact factor: 8.860

5.  c-Kit signaling determines neointimal hyperplasia in arteriovenous fistulae.

Authors:  Nikolaos Skartsis; Laisel Martinez; Juan Camilo Duque; Marwan Tabbara; Omaida C Velazquez; Arif Asif; Fotios Andreopoulos; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-03

6.  Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulas.

Authors:  Ming Liang; Qunying Guo; Fengzhang Huang; Guofeng Han; Ke Song; Jinlong Luo; Hunter Cheng; Hongzhen Hu; Eric K Peden; Changyi Chen; William E Mitch; Jie Du; Xiaodong Fu; Luan Truong; Jizhong Cheng
Journal:  Kidney Int       Date:  2019-02-21       Impact factor: 10.612

7.  The battlefield at arteriovenous crossroads: invading arterial smooth muscle cells occupy the outflow tract of fistulas.

Authors:  Joris I Rotmans; Taisiya Bezhaeva
Journal:  Kidney Int       Date:  2015-09       Impact factor: 10.612

8.  Mobilization of Endothelial Progenitor Cells Following Creation of Arteriovenous Access in Patients with End-Stage Renal Disease.

Authors:  Jun-Neng Roan; Chwan-Yau Luo; Mang-Da Tsai; I-Shuan Wu; Shih-Wei Chang; Chien-Chi Huang; Yau-Sheng Tsai; Chen-Fuh Lam
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

Review 9.  The Role of Endovascular Stents in Dialysis Access Maintenance.

Authors:  Mohamad El Kassem; Issam Alghamdi; Roberto I Vazquez-Padron; Arif Asif; Oliver Lenz; Tina Sanjar; Fadi Fayad; Loay Salman
Journal:  Adv Chronic Kidney Dis       Date:  2015-11       Impact factor: 3.620

10.  The anatomical sources of neointimal cells in the arteriovenous fistula.

Authors:  Roberto I Vazquez-Padron; Laisel Martinez; Juan C Duque; Loay H Salman; Marwan Tabbara
Journal:  J Vasc Access       Date:  2021-05-07       Impact factor: 2.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.